JPWO2023032995A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2023032995A5
JPWO2023032995A5 JP2023545612A JP2023545612A JPWO2023032995A5 JP WO2023032995 A5 JPWO2023032995 A5 JP WO2023032995A5 JP 2023545612 A JP2023545612 A JP 2023545612A JP 2023545612 A JP2023545612 A JP 2023545612A JP WO2023032995 A5 JPWO2023032995 A5 JP WO2023032995A5
Authority
JP
Japan
Prior art keywords
group
represent
compound according
anionic
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023545612A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023032995A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/032640 external-priority patent/WO2023032995A1/ja
Publication of JPWO2023032995A1 publication Critical patent/JPWO2023032995A1/ja
Publication of JPWO2023032995A5 publication Critical patent/JPWO2023032995A5/ja
Pending legal-status Critical Current

Links

JP2023545612A 2021-08-31 2022-08-30 Pending JPWO2023032995A1 (https=)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021141998 2021-08-31
JP2022100572 2022-06-22
PCT/JP2022/032640 WO2023032995A1 (ja) 2021-08-31 2022-08-30 化合物及びこれを用いた標識生体物質

Publications (2)

Publication Number Publication Date
JPWO2023032995A1 JPWO2023032995A1 (https=) 2023-03-09
JPWO2023032995A5 true JPWO2023032995A5 (https=) 2024-05-23

Family

ID=85411284

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023545612A Pending JPWO2023032995A1 (https=) 2021-08-31 2022-08-30

Country Status (4)

Country Link
US (1) US20240173437A1 (https=)
EP (1) EP4397672A4 (https=)
JP (1) JPWO2023032995A1 (https=)
WO (1) WO2023032995A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7787670B2 (ja) * 2021-08-31 2025-12-17 富士フイルム株式会社 化合物及びこれを用いた標識生体物質
WO2025047686A1 (ja) 2023-08-31 2025-03-06 富士フイルム株式会社 標的化薬物複合体及びこれを含む医薬、並びに、化合物

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4355097A (en) * 1997-05-01 1998-11-27 Minnesota Mining And Manufacturing Company Fluorogenic protease substrates based on dye-dimerization
EP0967219A4 (en) 1997-07-11 2002-09-11 Rikagaku Kenkyusho CONNECTIONS WITH ENERGY TRANSFER FUNCTION AND A METHOD FOR DNA BASE SEQUENCING USING THESE CONNECTIONS
AU7368800A (en) 1999-09-10 2001-04-10 Oncoimmunin, Inc. Compositions for the detection of enzyme activity in biological samples and methods of use thereof
JP2004508838A (ja) 2000-09-11 2004-03-25 ザ・トラスティーズ・オブ・コランビア・ユニバーシティー・イン・ザ・シティー・オブ・ニューヨーク 組合せ蛍光エネルギー移動タグ及びそれらの使用
EP1322710B2 (en) 2000-09-29 2015-02-18 Life Technologies Corporation Modified carbocyanine dyes and their conjugates
WO2010117420A2 (en) * 2009-03-30 2010-10-14 Pacific Biosciences Of California, Inc. Fret-labeled compounds and uses therefor
GB201220010D0 (en) 2012-11-07 2012-12-19 Oxford Biotherapeutics Ltd Therapeutic amd diagnostic target
CN117138060A (zh) 2014-10-07 2023-12-01 免疫医疗公司 抗体-药物缀合物的新辅助剂用途
EP4180455A1 (en) 2015-06-29 2023-05-17 Daiichi Sankyo Company, Limited Method for selectively manufacturing antibody-drug conjugate
CA3057419A1 (en) 2017-03-21 2018-09-27 Fujifilm Corporation Peptide compound and method for producing same, composition for screening use, and method for selecting peptide compound
JP2019172826A (ja) 2018-03-28 2019-10-10 富士フイルム株式会社 蛍光性化合物及びこれを用いた蛍光標識生体物質
WO2019230963A1 (ja) 2018-06-01 2019-12-05 富士フイルム株式会社 蛍光性化合物及びこれを用いた蛍光標識生体物質
MX2021008867A (es) * 2019-01-23 2021-08-19 Quantum Si Inc Composiciones reactantes marcadas de intensidad alta y metodos de secuenciamiento.
JP7628073B2 (ja) 2019-02-28 2025-02-07 富士フイルム株式会社 ペプチド化合物の製造方法、保護基形成用試薬、及び、芳香族複素環化合物
WO2020254654A1 (en) * 2019-06-21 2020-12-24 Centre National De La Recherche Scientifique Fluorescent complexes comprising two rhodamine derivatives and a nucleic acid molecule
JP7344982B2 (ja) 2019-11-21 2023-09-14 富士フイルム株式会社 化合物及びこれを用いた蛍光標識生体物質
JP7503919B2 (ja) 2020-03-11 2024-06-21 リンナイ株式会社 衣類乾燥機
WO2022040213A1 (en) * 2020-08-18 2022-02-24 Ultima Genomics, Inc. Reagents for labeling biomolecules
JP7444407B2 (ja) 2020-12-24 2024-03-06 株式会社Avad プログラム実行システム、制御装置及び制御プログラム

Similar Documents

Publication Publication Date Title
JPWO2023032995A5 (https=)
US5367066A (en) Oligonucleotides with selectably cleavable and/or abasic sites
US4725677A (en) Process for the preparation of oligonucleotides
DE68926137T2 (de) Pyrimidin-Nukleoside
JP3170241B2 (ja) ヌクレオチド試薬
JPH03500530A (ja) 新規な両親媒性核酸接合体
DE69007968T2 (de) Derivate von polyhydroxylierten molekülen, welche die einführung von mindestens einer verzweigung in ein oligonukleotid erlauben.
JP2021517126A5 (https=)
RU2013134746A (ru) Низкомолекулярные конъюгаты для внутриклеточной доставки биологически активных соединений
PT98720B (pt) Processo para a preparacao de derivados de fosfolipidos de nucleosidos e de composicoes farmaceuticas que os contem
CA2499036A1 (en) 1,3,5-triazines for treatment of viral diseases
JPWO2023278589A5 (https=)
JPWO2020233650A5 (https=)
JPWO2021070494A5 (https=)
EP0290583A1 (fr) OLIGONUCLEOTIDES -g(a).
Fries et al. Synthesis and biological evaluation of 5-fluoro-2'-deoxyuridine phosphoramidate analogs
WO1996001638A1 (en) Method of treating a neoplastic disease state by conjunctive therapy with 2'-fluoromethylidene derivatives and radiation or chemotherapy
CA2436958A1 (fr) Derives d'acyclonucleosides pyrimidiniques, leur procede de preparation et leur utilisation
JPWO2020063198A5 (https=)
KR960703937A (ko) 고체 지지체상에서 핵산을 합성하는 방법 및 이 방법에서 고체 지지체로서 유용한 화합물(process for solid support nucleic acid synthesis and compounds useful as solid supports in said process)
Charvet et al. Inhibition of human immunodeficiency virus type 1 replication by phosphonoformate-and phosphonoacetate-2', 3'-dideoxy-3'-thiacytidine conjugates
AU688052B2 (en) Oxathiolanes, method for their preparation and pharmaceutical compositions containing same
JPH03240795A (ja) 新規オリゴヌクレオチド誘導体及び抗ウイルス剤への使用
JPWO2023032996A5 (https=)
Moreno et al. Synthesis of 4-thiouridines with prodrug functionalization for RNA metabolic labeling